Risk of regorafenib-induced cardiovascular events in patients with solid tumors: A systematic review and meta-analysis

BACKGROUND: The present comparative meta-analysis was conducted to evaluate the cardiovascular events of regorafenib in patients with solid tumors. METHODS: Eligible studies from MEDLINE, Google Scholar, Cochrane Library, Clinical key, EBSCO publishing and Ovid, which had reported cardiovascular adv...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianxin, Wang, Junhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203579/
https://www.ncbi.nlm.nih.gov/pubmed/30313066
http://dx.doi.org/10.1097/MD.0000000000012705

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203579/
https://www.ncbi.nlm.nih.gov/pubmed/30313066
http://dx.doi.org/10.1097/MD.0000000000012705

Ejemplares similares